Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gohil

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Biochemical Pharmacology|February 5, 2000
Selective binding of the truncated form of the chemokine CKbeta8 (25-99) to CC chemokine receptor 1(CCR1)T A Berkhout, J Gohil, P Gonzalez, et al.
Current Computer-Aided Drug Design|July 15, 2016
A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1Anand S Chintakrindi, Elvis A F Martis, Devanshi J Gohil, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonistsJ Witherington, V Bordas, D G Cooper, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 3, 2014
Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from MumbaiDevanshi J Gohil, Sweta T Kothari, Pramod S Shinde, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compoundI T Forbes, D G Cooper, E K Dodds, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Biochemical Pharmacology|February 5, 2000
Selective binding of the truncated form of the chemokine CKbeta8 (25-99) to CC chemokine receptor 1(CCR1)T A Berkhout, J Gohil, P Gonzalez, et al.
Current Computer-Aided Drug Design|July 15, 2016
A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1Anand S Chintakrindi, Elvis A F Martis, Devanshi J Gohil, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonistsJ Witherington, V Bordas, D G Cooper, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 3, 2014
Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from MumbaiDevanshi J Gohil, Sweta T Kothari, Pramod S Shinde, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compoundI T Forbes, D G Cooper, E K Dodds, et al.
Pageof 2